NCT01693055View on ClinicalTrials.gov

Safety and Efficacy Evaluation of UltheraTM in Treatment of Baggy Eyelid

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Orbital Fat Prolapse
Interventions
DEVICE

UltheraTM 100 shots

UltheraTM 100 shots (infraorbital region 30shots, lateral orbital region 40shots, upper eyelid 30 shots) on the Rt, and Lt periorbital area, respectively using 1.5mm and 3.0mm probe

Trial Locations (1)

463-707

Seoul National Univ. Bundang Hospital, Gumi-dong, Bundang-gu, Seongnam-si

All Listed Sponsors
collaborator

Ulthera, Inc

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT01693055 - Safety and Efficacy Evaluation of UltheraTM in Treatment of Baggy Eyelid | Biotech Hunter | Biotech Hunter